Oncosec Medical Stock Net Income
ONCSDelisted Stock | USD 0.06 0 3.63% |
OncoSec Medical fundamentals help investors to digest information that contributes to OncoSec Medical's financial success or failures. It also enables traders to predict the movement of OncoSec Stock. The fundamental analysis module provides a way to measure OncoSec Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to OncoSec Medical stock.
OncoSec |
OncoSec Medical Company Net Income Analysis
OncoSec Medical's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current OncoSec Medical Net Income | (34.18 M) |
Most of OncoSec Medical's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, OncoSec Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, OncoSec Medical reported net income of (34.18 Million). This is 110.02% lower than that of the Biotechnology sector and 148.8% lower than that of the Health Care industry. The net income for all United States stocks is 105.99% higher than that of the company.
OncoSec Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses OncoSec Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of OncoSec Medical could also be used in its relative valuation, which is a method of valuing OncoSec Medical by comparing valuation metrics of similar companies.OncoSec Medical is currently under evaluation in net income category among its peers.
OncoSec Fundamentals
Return On Equity | -4.1 | |||
Return On Asset | -0.93 | |||
Current Valuation | 5.6 M | |||
Shares Outstanding | 5.96 M | |||
Shares Owned By Insiders | 28.01 % | |||
Shares Owned By Institutions | 5.83 % | |||
Number Of Shares Shorted | 192.06 K | |||
Price To Earning | (3.12) X | |||
Price To Book | 0.78 X | |||
EBITDA | (35.92 M) | |||
Net Income | (34.18 M) | |||
Cash And Equivalents | 19.48 M | |||
Cash Per Share | 0.50 X | |||
Total Debt | 6.17 M | |||
Debt To Equity | 0.76 % | |||
Current Ratio | 4.51 X | |||
Book Value Per Share | (1.85) X | |||
Cash Flow From Operations | (32.14 M) | |||
Short Ratio | 0.34 X | |||
Earnings Per Share | (20.31) X | |||
Target Price | 110.0 | |||
Number Of Employees | 40 | |||
Beta | 2.0 | |||
Market Capitalization | 1.65 M | |||
Total Asset | 21.88 M | |||
Retained Earnings | (285.96 M) | |||
Working Capital | 8.6 M | |||
Current Asset | 29.42 M | |||
Current Liabilities | 3.47 M | |||
Z Score | -23.08 | |||
Net Asset | 21.88 M |
About OncoSec Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze OncoSec Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of OncoSec Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of OncoSec Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Consideration for investing in OncoSec Stock
If you are still planning to invest in OncoSec Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the OncoSec Medical's history and understand the potential risks before investing.
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |